Results 211 to 220 of about 97,860 (303)

Safety, Efficacy, and Pharmacokinetics of Unecritinib (TQ‐B3101) in Pediatric Patients With Relapsed/Refractory Anaplastic Lymphoma Kinase‐Positive Anaplastic Large‐Cell Lymphoma: A Phase I Study

MedComm, Volume 7, Issue 11, November 2026.
This Phase I study evaluated unecritinib (TQ‐B3101) in pediatric patients with relapsed/refractory ALK+ anaplastic large‐cell lymphoma. Unecritinib showed a manageable safety profile without dose‐limiting toxicities and achieved remarkable efficacy, with a 100% overall response rate.
Suying Lu, Junting Huang, Ruiqing Cai, Yan Gao, Jia Zhu, Juan Wang, Yi Que, Zijun Zhen, Feifei Sun, Huiqiang Huang, Yizhuo Zhang   +10 more
wiley   +1 more source

Duffy testing to benefit children's population health: a cost-effectiveness analysis. [PDF]

Blood Adv
Merz LE, Ito S, Sra M, Ng DQ, Walkovich K, Achebe MO, Frustace P, van Havre N, Goshua G.   +8 more
europepmc   +1 more source

Metabolic Profiling Combined With Machine Learning for Assessing Clonal Hematopoiesis Status in Chronic Immune Thrombocytopenia: An Exploratory Analysis

MedComm, Volume 7, Issue 11, November 2026.
Clonal hematopoiesis (CH) may contribute to immune thrombocytopenia (ITP). Among 1817 patients with chronic ITP, CH occurred in 10.8%. Plasma metabolomes of 539 patients were profiled by untargeted LC‐MS/MS, revealing 14 metabolites distinguishing CH from non‐CH. Logistic regression combining these metabolites with sex, age, and platelet count achieved
Jia Chen, Qing Wen, Ting Sun, Xiaofan Liu, Feng Xue, Wei Liu, Rongfeng Fu, Mankai Ju, Xinyue Dai, Ying Chi, Wentian Wang, Renchi Yang, Yunfei Chen, Lei Zhang   +13 more
wiley   +1 more source

Predictors of low birth weight deliveries at a primary health care facility: Suhum Government Hospital, Ghana - a retrospective cross-sectional study. [PDF]

BMJ Public Health
Duah E, Lee Y, Han W, Osei KMO, Oh S, Aluma G, Konadu Asiedu EK, Akuoku M, Chun C, Badu K, Boateng SAA.   +10 more
europepmc   +1 more source

Navigating the Information Gap: Women's Experiences of Dichorionic Diamniotic (DCDA) Twin Pregnancy Care

Nursing Open, Volume 13, Issue 11, November 2026.
ABSTRACT Aim To explore women's lived experiences of dichorionic diamniotic twin pregnancies, including their information and support needs to inform future maternity care and service development. Design An empirical qualitative study guided by Braun and Clarke's reflexive thematic analysis.
Caroline O'Connor, Sara Leitao, Keelin O'Donoghue   +2 more
wiley   +1 more source

Association Between Transport Cost Burden, Basic Health Care Provision Fund (BHCPF) Enrolment, And Completion of Four Or More Antenatal Care Visits Among Pregnant Women in Ilorin South Local Government Area, Kwara State, Nigeria: A Mixed-Methods Study. [PDF]

Niger Med J
Adedeji MA, Manga MK, Membis NJ, Mathias T, Mfam DE, Yakubu IM.   +5 more
europepmc   +1 more source

Perinatal outcomes after implementation of a blended virtual and in‐person prenatal care model in integrated healthcare systems

Pregnancy, Volume 2, Issue 6, November 2026.
Abstract Background Traditional US prenatal care typically includes 12–14 standardized in‐person visits. COVID‐19‐related barriers accelerated adoption of blended virtual/in‐person prenatal care, but evidence from large, diverse populations is limited. Objective To compare perinatal outcomes after implementation of a blended prenatal care model versus ...
Michael J. Fassett, Emily V. West, Ericka C. Gibson, Linda S. Chong Tim, Chantal C. Avila, Jiaxiao M. Shi, Vicki Y. Chiu, Joanie WI. Chung, Erica E. Rudolph, Nehaa Khadka, Christopher J. Jentz, David M. Mosen, Jemma C. Nonog, Jocelyn W. Audelo, Darios Getahun   +14 more
wiley   +1 more source

A Case of Duffy-Null-Associated Neutropenia in a Patient With Chronic Myeloid Leukemia. [PDF]

Case Rep Hematol
Parekh A, Metzner-Sadurski J.
europepmc   +1 more source

Clozapine‐Associated Neutropenia With COVID‐19 Infection and the Role of Filgrastim

Progress in Neurology and Psychiatry, Volume 30, Issue 4, November 2026.
ABSTRACT Clozapine is the gold standard, evidence‐based treatment of choice for treatment‐resistant schizophrenia. However, clozapine can induce serious, life‐threatening adverse effects, including neutropenia and agranulocytosis. There is accumulating evidence to suggest that rechallenging with clozapine should be considered in most patients with ...
Devender Singh Yadav
wiley   +1 more source